Supplementary Figure 1. Treatment patterns in patients with metastatic non-small-cell lung cancer in the era of immunotherapy
Sankey diagram of treatment patterns during the study time period (August 2018 to December 2019) for patients with tumor PD-L1 expression
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Bild |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Stenehjem, David Lubinga, Solomon Betts, Keith A Tang, Wenxi Jenkins, Mads Yuan, Yongqin Hartman, John Rao, Sumati Lam, Jenny Waterhouse, David |
| description | Sankey diagram of treatment patterns during the study time period
(August 2018 to December 2019) for patients with tumor PD-L1 expression |
| doi_str_mv | 10.25402/fon.14413628 |
| format | Image |
| fullrecord | <record><control><sourceid>datacite_PQ8</sourceid><recordid>TN_cdi_datacite_primary_10_25402_fon_14413628</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_25402_fon_14413628</sourcerecordid><originalsourceid>FETCH-datacite_primary_10_25402_fon_144136283</originalsourceid><addsrcrecordid>eNqVjsFqwzAQRHXJoaQ59r4_YNey3ZJ7acg9votFWdsCaS2kNSGH_Hvk0n5ATzM8ZuAp9aabuv3om_Z9XLjWfa-7z_b4oh6XNUZPgVgw3eHkpjUR6BqGRCgbhogilDiD4627wjLcnMwQSDBLQRZ44SoH9L6y5D34lSewyJbSdpOZgBLCMoILYeWlgITx_qp2I_pMh9_cq-r0PXydqysKWidkYnKhiBndmB99U_TNn3733_0TbypVGg</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>image</recordtype></control><display><type>image</type><title>Supplementary Figure 1. Treatment patterns in patients with metastatic non-small-cell lung cancer in the era of immunotherapy</title><source>DataCite</source><creator>Stenehjem, David ; Lubinga, Solomon ; Betts, Keith A ; Tang, Wenxi ; Jenkins, Mads ; Yuan, Yongqin ; Hartman, John ; Rao, Sumati ; Lam, Jenny ; Waterhouse, David</creator><creatorcontrib>Stenehjem, David ; Lubinga, Solomon ; Betts, Keith A ; Tang, Wenxi ; Jenkins, Mads ; Yuan, Yongqin ; Hartman, John ; Rao, Sumati ; Lam, Jenny ; Waterhouse, David</creatorcontrib><description>Sankey diagram of treatment patterns during the study time period
(August 2018 to December 2019) for patients with tumor PD-L1 expression <1%
(A), 1%–49% (B), and ≥50% (C). 1L: first-line; 2L: second-line; 3L: third-line;
Nivo: nivolumab; Pembro: pembrolizumab.</description><identifier>DOI: 10.25402/fon.14413628</identifier><language>eng</language><publisher>Taylor & Francis</publisher><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776,1888</link.rule.ids><linktorsrc>$$Uhttps://commons.datacite.org/doi.org/10.25402/fon.14413628$$EView_record_in_DataCite.org$$FView_record_in_$$GDataCite.org$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Stenehjem, David</creatorcontrib><creatorcontrib>Lubinga, Solomon</creatorcontrib><creatorcontrib>Betts, Keith A</creatorcontrib><creatorcontrib>Tang, Wenxi</creatorcontrib><creatorcontrib>Jenkins, Mads</creatorcontrib><creatorcontrib>Yuan, Yongqin</creatorcontrib><creatorcontrib>Hartman, John</creatorcontrib><creatorcontrib>Rao, Sumati</creatorcontrib><creatorcontrib>Lam, Jenny</creatorcontrib><creatorcontrib>Waterhouse, David</creatorcontrib><title>Supplementary Figure 1. Treatment patterns in patients with metastatic non-small-cell lung cancer in the era of immunotherapy</title><description>Sankey diagram of treatment patterns during the study time period
(August 2018 to December 2019) for patients with tumor PD-L1 expression <1%
(A), 1%–49% (B), and ≥50% (C). 1L: first-line; 2L: second-line; 3L: third-line;
Nivo: nivolumab; Pembro: pembrolizumab.</description><fulltext>true</fulltext><rsrctype>image</rsrctype><creationdate>2021</creationdate><recordtype>image</recordtype><sourceid>PQ8</sourceid><recordid>eNqVjsFqwzAQRHXJoaQ59r4_YNey3ZJ7acg9votFWdsCaS2kNSGH_Hvk0n5ATzM8ZuAp9aabuv3om_Z9XLjWfa-7z_b4oh6XNUZPgVgw3eHkpjUR6BqGRCgbhogilDiD4627wjLcnMwQSDBLQRZ44SoH9L6y5D34lSewyJbSdpOZgBLCMoILYeWlgITx_qp2I_pMh9_cq-r0PXydqysKWidkYnKhiBndmB99U_TNn3733_0TbypVGg</recordid><startdate>20210414</startdate><enddate>20210414</enddate><creator>Stenehjem, David</creator><creator>Lubinga, Solomon</creator><creator>Betts, Keith A</creator><creator>Tang, Wenxi</creator><creator>Jenkins, Mads</creator><creator>Yuan, Yongqin</creator><creator>Hartman, John</creator><creator>Rao, Sumati</creator><creator>Lam, Jenny</creator><creator>Waterhouse, David</creator><general>Taylor & Francis</general><scope>DYCCY</scope><scope>PQ8</scope></search><sort><creationdate>20210414</creationdate><title>Supplementary Figure 1. Treatment patterns in patients with metastatic non-small-cell lung cancer in the era of immunotherapy</title><author>Stenehjem, David ; Lubinga, Solomon ; Betts, Keith A ; Tang, Wenxi ; Jenkins, Mads ; Yuan, Yongqin ; Hartman, John ; Rao, Sumati ; Lam, Jenny ; Waterhouse, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-datacite_primary_10_25402_fon_144136283</frbrgroupid><rsrctype>images</rsrctype><prefilter>images</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Stenehjem, David</creatorcontrib><creatorcontrib>Lubinga, Solomon</creatorcontrib><creatorcontrib>Betts, Keith A</creatorcontrib><creatorcontrib>Tang, Wenxi</creatorcontrib><creatorcontrib>Jenkins, Mads</creatorcontrib><creatorcontrib>Yuan, Yongqin</creatorcontrib><creatorcontrib>Hartman, John</creatorcontrib><creatorcontrib>Rao, Sumati</creatorcontrib><creatorcontrib>Lam, Jenny</creatorcontrib><creatorcontrib>Waterhouse, David</creatorcontrib><collection>DataCite (Open Access)</collection><collection>DataCite</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Stenehjem, David</au><au>Lubinga, Solomon</au><au>Betts, Keith A</au><au>Tang, Wenxi</au><au>Jenkins, Mads</au><au>Yuan, Yongqin</au><au>Hartman, John</au><au>Rao, Sumati</au><au>Lam, Jenny</au><au>Waterhouse, David</au><format>book</format><genre>unknown</genre><ristype>GEN</ristype><title>Supplementary Figure 1. Treatment patterns in patients with metastatic non-small-cell lung cancer in the era of immunotherapy</title><date>2021-04-14</date><risdate>2021</risdate><abstract>Sankey diagram of treatment patterns during the study time period
(August 2018 to December 2019) for patients with tumor PD-L1 expression <1%
(A), 1%–49% (B), and ≥50% (C). 1L: first-line; 2L: second-line; 3L: third-line;
Nivo: nivolumab; Pembro: pembrolizumab.</abstract><pub>Taylor & Francis</pub><doi>10.25402/fon.14413628</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | DOI: 10.25402/fon.14413628 |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_datacite_primary_10_25402_fon_14413628 |
| source | DataCite |
| title | Supplementary Figure 1. Treatment patterns in patients with metastatic non-small-cell lung cancer in the era of immunotherapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T20%3A42%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-datacite_PQ8&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.au=Stenehjem,%20David&rft.date=2021-04-14&rft_id=info:doi/10.25402/fon.14413628&rft_dat=%3Cdatacite_PQ8%3E10_25402_fon_14413628%3C/datacite_PQ8%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |